| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |